Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    In last 3 years
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Chinese interpretation of Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) and Ruijin clinical practice
    YAN Chao, LU Sheng, YAN Min, ZHU Zhenggang
    Journal of Surgery Concepts & Practice    2023, 28 (04): 326-354.   DOI: 10.16139/j.1007-9610.2023.04.010
    Abstract930)   HTML23)    PDF(pc) (4954KB)(2291)       Save

    “Japanese Gastric Cancer Treatment Guidelines” have been important guidelines for the treatment of gastric cancer in Japan and worldwide. The English version “Japanese Gastric Cancer Treatment Guidelines 2021 (6th Edition)” published in January 2023 consists of two parts. The first part includes diagnostic and treatment methods, such as surgery, endoscopic resection, chemotherapy, follow-up. The second part addresses clinical issues, including recommendations and explanations for clinical hot topics. This article will provide a Chinese interpretation of the guidelines and briefly introduce our hospital's clinical practice in the diagnosis and treatment of gastric cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in surgical treatment of hepatocellular carcinoma
    HUANG Jiwei, QIU Guoteng, ZENG Yong
    Journal of Surgery Concepts & Practice    2022, 27 (02): 113-118.   DOI: 10.16139/j.1007-9610.2022.02.005
    Abstract196)   HTML1)    PDF(pc) (554KB)(1550)       Save
    Reference | Related Articles | Metrics | Comments0
    Value of proton and heavy ion radiotherapy in treatment of retroperitoneal sarcoma
    WANG Zheng, BAO Cihang, JIANG Guoliang
    Journal of Surgery Concepts & Practice    2022, 27 (06): 506-510.   DOI: 10.16139/j.1007-9610.2022.06.05
    Abstract301)   HTML14)    PDF(pc) (826KB)(1542)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    The fifth edition of WHO classification of digestive system tumors: update and progress on biliary system tumors
    LUO Fangxiu, MA Qianchen, YUAN Fei
    Journal of Surgery Concepts & Practice    2023, 28 (02): 124-131.   DOI: 10.16139/j.1007-9610.2023.02.08
    Abstract702)   HTML18)    PDF(pc) (3365KB)(1218)       Save

    Overall, there was little change in biliary system tumors of the 5th edition of WHO classification of digestive system tumors after update. The three-tiered classification of biliary intraepithelial neoplasia changed to two-tiered system: high-grade and low-grade, in the section of benign tumors and precancerous lesions. And both intracholecystic and intraductal papillary tumors associated with invasive carcinoma were added. The classification of intrahepatic bile duct tumors introduced parts of bile duct adenoma and bile duct adenofibroma, which were mentioned previously in the differential diagnosis with bile duct carcinoma. Intrahepatic cholangiocarcinoma was divided into small bile duct subtype and large bile duct subtype in the 5th edition of WHO classification, and the names of cholangiocellular carcinoma and cholangiole cell carcinoma were no longer recommended to use. Extrahepatic cholangiocarcinoma was listed as a separate part for the first time, including squamous cell carcinoma, adenosquamous carcinoma and undifferentiated carcinoma in addition to common histological types. Some new contents of molecular pathology in the 5th edition of WHO classification were added, which provided the basis for precise classification and diagnosis of tumors in biliary system.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 5th edition WHO classification and staging of digestive system tumors: colorectal tumors
    YU Yingyan
    Journal of Surgery Concepts & Practice    2021, 26 (04): 312-317.   DOI: 10.16139/j.1007-9610.2021.04.008
    Abstract1118)   HTML54)    PDF(pc) (589KB)(850)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 2022 edition of “guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China”
    XU Bojin, PENG Wenfang, HUANG Shan
    Journal of Surgery Concepts & Practice    2023, 28 (06): 512-519.   DOI: 10.16139/j.1007-9610.2023.06.05
    Abstract198)   HTML1)    PDF(pc) (889KB)(782)       Save

    “Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China” (2022) (referred to as the “guidelines”) was officially published in August 2022 in the Chinese Journal of Endocrine Metabolism. These guidelines have been extensively updated from the 2007 version, with 15 sections covering the etiology, clinical manifestations, diagnosis, evaluation, and treatment of hyperthyroidism, as well as the management of specific types of thyrotoxicosis. The new version guidelines proposed 107 recommended opinions supported by stronger evidence, offering comprehensive and reliable guidance for clinical doctors and medical professionals dealing with thyrotoxicosis. This article aimed to extract the key points and recommended strategies from the guidelines to help clinical doctors better understand and apply the latest guiding principles.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Development and prospects of ERCP in China
    LI Wen
    Journal of Surgery Concepts & Practice    2023, 28 (04): 279-282.   DOI: 10.16139/j.1007-9610.2023.04.001
    Abstract483)   HTML10)    PDF(pc) (838KB)(616)       Save

    Endoscopic retrograde cholangio-pancreatography (ERCP) is an interventional endoscopic technique aimed at the diagnoses and treatment of biliary and pancreatic diseases under the guidance of endoscopy and X-ray ima-ging. ERCP was introduced into China from the 1970s. In the 1990s, ERCP was gradually popularized and applied in China with the development of medical technique and improvement of equipment, more medical institutions started to carry out ERCP. After 2000, ERCP technology and equipment were further upgraded and improved in China. Many secondary and tertiary hospitals began to establish the ERCP centers. Meanwhile, workshops and training also facilitated the teaching and practice of ERCP and cultivated more professionals of ERCP. In recent years, the technical level of ERCP in China has been continuously improved, and technologies and equipments are constantly updated and iterated. Currently, ERCP has become one of important techniques in the endoscopic field, playing an important role in the diagnosis and treatment of biliary and pancreatic diseases. The vigorous development of ERCP in China is attributed to the advancement of medical science, the improvement of technology and the efforts of generations of ERCP specialists.

    Reference | Related Articles | Metrics | Comments0
    Conversion therapy for intrahepatic cholangiocarcinoma: status and perspectives
    FANG Cheng, XIA Yong, WANG Kui, SHEN Feng
    Journal of Surgery Concepts & Practice    2022, 27 (02): 107-112.   DOI: 10.16139/j.1007-9610.2022.02.004
    Abstract207)   HTML6)    PDF(pc) (585KB)(378)       Save
    Reference | Related Articles | Metrics | Comments0
    Differentiated thyroid carcinoma: 4th edition WHO pathological classification and future
    TANG Juan, LIU Zhiyan
    Journal of Surgery Concepts & Practice    2021, 26 (06): 504-509.   DOI: 10.16139/j.1007-9610.2021.06.009
    Abstract303)   HTML16)    PDF(pc) (1040KB)(370)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Treatment and combined viscerectomy for locally advanced colorectal cancer
    GU Jin
    Journal of Surgery Concepts & Practice    2021, 26 (04): 290-296.   DOI: 10.16139/j.1007-9610.2021.04.004
    Abstract415)   HTML13)    PDF(pc) (1732KB)(362)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Stage on development of pathophysiology of gallbladder stone and personalized diagnosis and treatment
    ZHENG Yamin, GU Liguo, XU Chen
    Journal of Surgery Concepts & Practice    2023, 28 (02): 94-99.   DOI: 10.16139/j.1007-9610.2023.02.02
    Abstract439)   HTML10)    PDF(pc) (799KB)(328)       Save

    Gallbladder stone (GS) is a common disease. There are no obvious symptoms at early stage for the patient with GS. Obstruction will cause acute cholecystitis. Secondary obstructive cholangitis of GS, biliary pancreatitis, gallbladder cancer due to GS would be serious. Many guidelines and consensuses have been published in the world and from many professional organizations, promoting the normative diagnosis and treatment of GS. However, there are still a lot of controversial issues. Currenly, there is a lack of study on the whole course of GS with large samples. Prevention and early diagnosis with treatment of GS are neglected. It results in insufficient personalized diagnosis and treatment. In order to have the prevention, diagnosis, treatment, prognosis and follow-up which are carried out better, the authors divided the course of GS into four stages according to the pathophysiological characteristics of the occurrence, development and outcome of GS. There are: ①stage of stone forming; ②asymptomatic period without obstruction; ③inflammation and infection stage, inclu-ding obstructive inflammation, pyogenic gangrene, perforation abscess; ④stage of secondary lesions, including abnormal gallbladder morphology and function, GS shift, gallbladder carcinoma. According to the pathophysiological staging, it is beneficial to the personalized diagnosis and treatment based on the standard management for the patients who can benefit more.

    Reference | Related Articles | Metrics | Comments0
    Evaluation and technical key points of pancreaticojejunostomy
    XIE Xuehai, YANG Yinmo
    Journal of Surgery Concepts & Practice    2022, 27 (01): 1-5.   DOI: 10.16139/j.1007-9610.2022.01.001
    Abstract426)   HTML8)    PDF(pc) (1030KB)(327)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment
    CHEN Xuanwu, YANG Chuanyu, JIANG Minjie, DU Weidong
    Journal of Surgery Concepts & Practice    2022, 27 (01): 87-90.   DOI: 10.16139/j.1007-9610.2022.01.020
    Abstract654)   HTML26)    PDF(pc) (407KB)(325)       Save

    Gallbladder adenomyomatosis(GA) is a relatively rare benign disease of unknown both etiology and pathogenesis. The development of imaging technology improved diagnosis of GA. Some believed that GA related to gallbladder cancer, which is still controversial. Preventive cholecystectomy was proposed to treat GA and some GA could be followed up. Therefore no consensus of treatment of GA is present now. Etiology, pathogenesis, diagnosis and treatment of GA were included in this article.

    Reference | Related Articles | Metrics | Comments0
    Endoscopic and robotic breast surgery: present and future—the experience of West China Hospital
    XIE Yanyan, LU Qing, DU Zhenggui
    Journal of Surgery Concepts & Practice    2022, 27 (05): 396-402.   DOI: 10.16139/j.1007-9610.2022.05.004
    Abstract313)   HTML14)    PDF(pc) (1483KB)(309)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Brief introduction to technology development of nerve monitoring during thyroid surgery in China
    Ll Changlin, SUN Hui
    Journal of Surgery Concepts & Practice    2021, 26 (06): 482-485.   DOI: 10.16139/j.1007-9610.2021.06.004
    Abstract283)   HTML3)    PDF(pc) (553KB)(299)       Save
    Reference | Related Articles | Metrics | Comments0
    Retroperitoneal tumor: pathological diagnosis and differential diagnosis
    WANG Jian
    Journal of Surgery Concepts & Practice    2022, 27 (06): 500-505.   DOI: 10.16139/j.1007-9610.2022.06.04
    Abstract293)   HTML13)    PDF(pc) (645KB)(298)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Diagnosis and treatment of superior mesenteric artery syndrome
    NI Jiaqi, WU Weize
    Journal of Surgery Concepts & Practice    2021, 26 (04): 370-372.   DOI: 10.16139/j.1007-9610.2021.04.017
    Abstract267)   HTML9)    PDF(pc) (342KB)(291)       Save
    Reference | Related Articles | Metrics | Comments0
    Summary and prospect of perioperative comprehensive treatment for gastric cancer in China
    LIU Wentao, LIU Fukun
    Journal of Surgery Concepts & Practice    2023, 28 (01): 36-41.   DOI: 10.16139/j.1007-9610.2023.01.06
    Abstract316)   HTML7)    PDF(pc) (860KB)(286)       Save

    Most of the patients with gastric cancer in China have been at the middle and advanced stages during diagnostic and treatment with poor prognosis overall. Perioperative radiotherapy, chemotherapy, immune therapy and other comprehensive treatment methods for gastric cancer patients preoperative and intraoperation may reduce tumor staging, increase the rate of surgical resection and prolong the time of patient survival. Perioperative comprehensive treatment has developed more than 30 years in China. Many results from relevant research were gotten combined with laying down the consensus and guidelines, and applied to clinic in recent years. With the emergence and development of new technologies and new strategies for comprehensive treatment, perioperative comprehensive treatment and conversion therapy will improve at much extent the rate of survival for gastric cancer patients in China.

    Reference | Related Articles | Metrics | Comments0
    Retrospective study on Bethesda Ⅴ thyroid nodule in diagnosis of papillary thyroid carcinoma: retrospective study
    YAN Shouyi, CHEN Hongbin, ZHANG Liyong, WANG Bo, CAI Shaojun, LIN Siying, ZHAO Wenxin
    Journal of Surgery Concepts & Practice    2021, 26 (06): 512-516.   DOI: 10.16139/j.1007-9610.2021.06.011
    Abstract842)   HTML4)    PDF(pc) (542KB)(284)       Save
    Objective To study on preoperative diagnosis of papillary thyroid carcinoma (PTC) with Bethesda Ⅴ thyroid nodules retrospectively and to explore the differences of clinical parameters between Bethesda Ⅴ and Ⅵ thyroid nodules. Methods The clinical data of 430 patients were analyzed. Results Univariate analysis showed that there were significant differences of Bethesda Ⅴ nodules in nodule boundary, tumor size and echo between PTC group of 159 cases and benign group of 20 cases (P<0.05). It was shown from multivariate analysis that nodule boundary, tumor size and echo were risk factors for malignant diagnosis of BethesdaⅤnodule. The differences were present significantly in TI-RADS grade, aspect ratio and echo between Bethesda ⅤPTC group of 159 case and Bethesda Ⅵ thyroid nodule group of 251 cases (P<0.05). Further multivariate analysis showed that TI-RADS grade, aspect ratio, relation of nodule with capsule, thyroid peroxidase antibody level and echo were the risk factors for the diagnosis of PTC. Conclusions Bethesda Ⅴ nodules with higher grade of TI-RADS are malignant more possibly and those with lower grade of TI-RADS need to be evaluated such as thyroid nodules sizes, relation of nodules with capsule and thyroid peroxidase antibody level.
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Controversy over the medial border of lymph node dissection during CME/D3 surgery of right colon cancer
    SUN Yueming, ZHANG Dongsheng
    Journal of Surgery Concepts & Practice    2023, 28 (03): 202-207.   DOI: 10.16139/j.1007-9610.2023.03.005
    Abstract506)   HTML5)    PDF(pc) (929KB)(276)       Save

    Radical surgery is the most important treatment for colon cancer. The development and application of complete mesentery excision (CME)/D3 lymph node dissection has promoted the standardization of surgical techniques for colon cancer. Right colon cancer surgery is relatively complicated, and is a research hotspot currently. The issues involved the range of lymph node dissection, the range of bowel resection, and the method of bowel reconstruction. The medial border of lymph node dissection for right colon cancer is one of the controversies. The left side of the superior mesenteric vein is generally considered to be the medial border of CME/D3 dissection in right colon cancer surgery. However, with the in-depth development of related research, some scholars believed that the left side of the superior mesenteric artery should be used as the medial border for lymph node dissection. This approach is more consistent with the principle of CME, and can achieve complete lymph node dissection. However, its clinical significance still needs to be evaluated with further research. This article discusses the selection of medial border of lymph node dissection for right colon cancer, hoping to provide reference for clinical practice.

    Reference | Related Articles | Metrics | Comments0